TxCell

Develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases

Total raised

€11M

€11,000,000

Funding rounds

Investors

distinct backers

Active since

2017-01

latest 2017-01

Funding by year

EUR raised per year

High confidence

Raise-next likelihood14

base rate 38% for Growth/Late

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2017-02-01	Growth/Late	€11M	Auriga Partners,Bpifrance	View deal →

same sector or country